INTRAVENOUS IMMUNOGLOBULINS: USE AND ADVERSE EVENTS

被引：0
|
作者：
Fabbri, S. [1 ]
Ursino, G. [1 ]
Cabella, I [1 ]
Garnero, M. [1 ]
Gemelli, C. [1 ]
Reni, L. [1 ]
Schenone, A. [1 ]
Grandis, M. [1 ]
机构：
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [21] INTRAVENOUS IMMUNOGLOBULINS - PHARMACOLOGICAL ASPECTS AND THERAPEUTIC USE
    HASSIG, A
    VOX SANGUINIS, 1986, 51 (01) : 10 - 17
  • [22] The use of intravenous immunoglobulins in the treatment of neuromuscular disorders
    Voltz, R
    Hohlfeld, R
    CURRENT OPINION IN NEUROLOGY, 1996, 9 (05) : 360 - 366
  • [23] Human polyclonal immunoglobulins for intravenous use and transplantation
    Haymann, JP
    Glotz, D
    NEPHROLOGIE, 1999, 20 (03): : 139 - 143
  • [24] Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature
    Shaye Kivity
    Uriel Katz
    Natalie Daniel
    Udi Nussinovitch
    Neophytos Papageorgiou
    Yehuda Shoenfeld
    Clinical Reviews in Allergy & Immunology, 2010, 38 : 201 - 269
  • [25] Human polyclonal immunoglobulins for intravenous use and transplantation
    Haymann, JP
    Glotz, D
    INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 237 - 242
  • [26] PEPSIN DOSE RESIDUAL IN IMMUNOGLOBULINS FOR INTRAVENOUS USE
    REUGE, C
    REVUE FRANCAISE DE TRANSFUSION ET IMMUNO-HEMATOLOGIE, 1988, 31 (01): : 61 - 63
  • [27] Association of intravenous immunoglobulins and corticosteroids may lead to thrombotic events
    Feuillet, L
    Guedj, E
    Milandre, L
    Habib, G
    Pelletier, J
    Cherif, AA
    JOURNAL OF NEUROLOGY, 2004, 251 : 184 - 185
  • [28] Potential underreporting of intravenous phenytoin adverse events
    Collins, M
    Gidal, BE
    Garnett, WRR
    Reinfeldt, G
    Tusch, GM
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (01) : 111 - 112
  • [29] ADVERSE EVENTS ASSOCIATED WITH INTRAVENOUS IMMUNOGLOBULIN IN THAILAND
    Sriphiromya, P.
    VALUE IN HEALTH, 2016, 19 (07) : A824 - A824
  • [30] Adverse events associated with intravenous immunoglobulin therapy
    Hamrock, DJ
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (04) : 535 - 542
12345